Figure 2.
Chemical structure of ruthenium anticancer drugs: RuIII compounds indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1019), imidazolium trans-[tetrachlorido(DMSO)(1H-imidazole)ruthenate(III)] (NAMI-A), RAPTA-T.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.